高盛:安踏體育遭股東減持令短期股價受壓,但長線前景正面
安踏體育遭控股股東計劃配售股份,於配售完成後對安踏體育持股量將由50.8%降至47.6%。
高盛發表報告表示,參考安踏過往主要股東配股減持歷史(分別爲2009年10月、2014年10月及2017年3月,公佈配股後當日股價各跌7%、8%及8%),相信主要股東減持行動對其短期股價有一定的下行壓力。
高盛稱,重申對安踏體育買入評級及未來12個月目標價158港元,此相當於預測2025年市盈率26倍,相信公司在內地體育用品行業增長長期前景。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.